Schizophrenia, Bipolar Disorder, and the Psychosis Continuum
Awareness of differences between psychosis in schizophrenia and bipolar disorder and varying presentations in patients can assist providers with diagnosis and treatment.
Schizophrenia and Psychoses
SCHIZOPHRENIA AND PSYCHOSES
Featured Article
Latest News
Panel Delivers Consensus on Tardive Dyskinesia Diagnosis and Treatment
A group of tardive dyskinesia experts has concluded that individuals taking antipsychotics should receive regular assessments, tardive dyskinesia may be indicated by mild movements isolated to 1 body area, an overall assessment of treatment is required for management, and thorough caregiver/patient discussions are required.
Salience Abnormalities May Play a Role in the Reward System in Schizophrenia
A study found a link between D2 receptor blockade, BOLD signal normalization, and treatment response in patients with schizophrenia.
FDA: Serious Complications Following Clozapine-Induced Constipation
The update was prompted by an FDA review of 10 cases of constipation in clozapine-treated patients that resulted in serious complications.
FDA to Review Novel Antipsychotic for Schizophrenia, Bipolar I Disorder
The FDA has accepted for review the New Drug Application (NDA) for ALKS 3831 (Alkermes) for the treatment of schizophrenia and bipolar I disorder.
Antipsychotic Use Safer Than No Use in Schizophrenia
Among patients with schizophrenia, long-term antipsychotic use does not appear to increase severe physical morbidity or somatic hospitalization, and mortality is lower for antipsychotic use compared with no use.
Is There Genetic Overlap Between BMI and Major Psychiatric Disorders?
The findings suggest that factors such as antipsychotic treatment, diet, or lifestyle may contribute to weight gain in patients with long-term disease.
Lumateperone Shows Promise as Treatment for Schizophrenia
Current antipsychotic therapy, effective primarily for positive symptoms but limited with negative symptoms, may be related to serious adverse effects, including motor impairments, prolactin abnormalities, and cardiometabolic disturbances.
Immune-HPA Axis Dysregulation and Stress Linked to Postpartum Psychosis
The researchers noted that recent stressful life events, perceived stress, daily cortisol levels, and high sensitivity C-reactive protein levels accounted for 78% of the variance between women with postpartum psychosis and healthy controls and 46% of the variance between at-risk women and healthy controls.
Olanzapine, Clozapine Show Worst Metabolic Effects Among Antipsychotics
Symptom reduction was significantly correlated with poor metabolic adverse effects, including weight gain, elevated BMI, and higher total cholesterol.
Study Recommends Revised CAPE-P15 Cutoff Values for Detecting Psychotic Experiences
The investigators recommended revising the CAPE-P15 cutoff thresholds to 1.30 and 1.29 for the frequency and distress subscales, respectively. These cutoff values have high sensitivity for psychotic experiences.
Want to read more?
Please login or register first to view this content.
Next post in Schizophrenia and Psychoses
